Search

everythinglearnresearchcommunity

for

Search:↓

Nonactivated low leukocyte PRP injections can significantly increase hair and follicle density in women with alopecia.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Including androgens in hormone therapy may lower breast cancer risk.

New Finasteride conjugate improves prostate treatment and vital signs in rats.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

PRP preparation partially activates platelets, causing varied growth factor release.

SDG helps reduce BPH effects in rats.

Fenugreek extract may help treat benign prostatic hyperplasia.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The estrogen receptor pathway controls hair growth cycles and affects skin cell growth.

The piRNA pathway genes are crucial in early development and may influence sex differentiation through hormone regulation.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Blocking androgens in male rats increased estrogen and made them more active.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

Cyproterone acetate was effective in treating acne, hirsutism, and alopecia with few side effects.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

The PTGER2 gene is highly active in Cashmere goat skin and its activity changes with the hair growth cycle.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Testosterone and some of its forms can strongly stimulate oil gland growth in skin.

Early hormones shape sex-specific differences in rat glands.

Human hair can be used to measure reproductive hormones.

Using testosterone-stimulated weanling rats can effectively replace castrated rats for anti-androgen testing, reducing animal stress.

15d‐PGJ2 cream protects against UVB-induced skin damage in mice.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Prolactin affects hair growth cycles and can cause early hair follicle regression.